Metraipolis › archive › dc_8a52161c062c

Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies — Europe PMC PMID:41671401

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41671401
DOI
10.1158/0008-5472.can-24-2758
License (as archived)
solo-consultazione
Archived
2026-11-02T21:42:24.894Z
SHA-256 of the archived text
4f9c2c730a15dc2eaa66d107307891f0859106ab5fccbddf2f19a169dbbea357
Stable URL of this page
https://metraipolis.com/documento/dc_8a52161c062c

How to cite

Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies — Europe PMC PMID:41671401 — Europe PMC (en), https://europepmc.org/article/MED/41671401 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a52161c062c (Metraipolis archive dc_8a52161c062c, sha256 4f9c2c730a15dc2eaa66d107307891f0859106ab5fccbddf2f19a169dbbea357)
BibTeX
@misc{dc8a52161c062c,
  title = {Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies — Europe PMC PMID:41671401},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41671401},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a52161c062c; sha256 4f9c2c730a15dc2eaa66d107307891f0859106ab5fccbddf2f19a169dbbea357},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41671401. Agents can read the archived copy with the MCP tool read_document.